288 related articles for article (PubMed ID: 25243855)
1. Influence of early zoledronic acid administration on bone marrow fat in ovariectomized rats.
Li GW; Xu Z; Chang SX; Zhou L; Wang XY; Nian H; Shi X
Endocrinology; 2014 Dec; 155(12):4731-8. PubMed ID: 25243855
[TBL] [Abstract][Full Text] [Related]
2. Panax notoginseng saponins mitigate ovariectomy-induced bone loss and inhibit marrow adiposity in rats.
Fan JZ; Wang Y; Meng Y; Li GW; Chang SX; Nian H; Liang YJ
Menopause; 2015 Dec; 22(12):1343-50. PubMed ID: 26035148
[TBL] [Abstract][Full Text] [Related]
3. Icariin prevents ovariectomy-induced bone loss and lowers marrow adipogenesis.
Li GW; Xu Z; Chang SX; Nian H; Wang XY; Qin LD
Menopause; 2014 Sep; 21(9):1007-16. PubMed ID: 24552978
[TBL] [Abstract][Full Text] [Related]
4. Marrow adiposity recovery after early zoledronic acid treatment of glucocorticoid-induced bone loss in rabbits assessed by magnetic resonance spectroscopy.
Li GW; Chang SX; Fan JZ; Tian YN; Xu Z; He YM
Bone; 2013 Feb; 52(2):668-75. PubMed ID: 23142803
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of bisphenol A diglicydyl ether on bone quality and marrow adiposity in ovary-intact and ovariectomized rats.
Li G; Xu Z; Hou L; Li X; Li X; Yuan W; Polat M; Chang S
Am J Physiol Endocrinol Metab; 2016 Dec; 311(6):E922-E927. PubMed ID: 27756728
[TBL] [Abstract][Full Text] [Related]
6. The beneficial effect of icaritin on osteoporotic bone is dependent on the treatment initiation timing in adult ovariectomized rats.
Peng S; Zhang G; Zhang BT; Guo B; He Y; Bakker AJ; Pan X; Zhen W; Hung L; Qin L; Leung WN
Bone; 2013 Jul; 55(1):230-40. PubMed ID: 23486180
[TBL] [Abstract][Full Text] [Related]
7. Effects of a beta 3 adrenergic receptor agonist on bone and bone marrow adipocytes in the tibia and lumbar spine of the ovariectomized rat.
Kurabayashi T; Tomita M; Matsushita H; Honda A; Takakuwa K; Tanaka K
Calcif Tissue Int; 2001 Apr; 68(4):248-54. PubMed ID: 11353953
[TBL] [Abstract][Full Text] [Related]
8. Does exercise modify the effects of zoledronic acid on bone mass, microarchitecture, biomechanics, and turnover in ovariectomized rats?
Lespessailles E; Jaffré C; Beaupied H; Nanyan P; Dolléans E; Benhamou CL; Courteix D
Calcif Tissue Int; 2009 Aug; 85(2):146-57. PubMed ID: 19609736
[TBL] [Abstract][Full Text] [Related]
9. Antiosteoporotic activity of echinacoside in ovariectomized rats.
Li F; Yang X; Yang Y; Guo C; Zhang C; Yang Z; Li P
Phytomedicine; 2013 Apr; 20(6):549-57. PubMed ID: 23428402
[TBL] [Abstract][Full Text] [Related]
10. Effect of zoledronic acid on vertebral marrow adiposity in postmenopausal osteoporosis assessed by MR spectroscopy.
Yang Y; Luo X; Yan F; Jiang Z; Li Y; Fang C; Shen J
Skeletal Radiol; 2015 Oct; 44(10):1499-505. PubMed ID: 26130070
[TBL] [Abstract][Full Text] [Related]
11. Effect of zoledronic acid on osseointegration of titanium implants: an experimental study in an ovariectomized rabbit model.
Yildiz A; Esen E; Kürkçü M; Damlar I; Dağlioğlu K; Akova T
J Oral Maxillofac Surg; 2010 Mar; 68(3):515-23. PubMed ID: 20171470
[TBL] [Abstract][Full Text] [Related]
12. Effect of zoledronic acid on spinal fusion outcomes in an ovariectomized rat model of osteoporosis.
Yasen M; Li X; Jiang L; Yuan W; Che W; Dong J
J Orthop Res; 2015 Sep; 33(9):1297-304. PubMed ID: 26011820
[TBL] [Abstract][Full Text] [Related]
13. Additive effects of zoledronic acid and propranolol on bone density and biochemical markers of bone turnover in osteopenic ovariectomized rats.
Khajuria DK; Razdan R; Mahapatra DR
Rev Bras Reumatol; 2015; 55(2):103-12. PubMed ID: 25582996
[TBL] [Abstract][Full Text] [Related]
14. Antiosteoporotic activity of Du-Zhong-Wan water extract in ovariectomized rats.
Li F; Yang X; Bi J; Yang Z; Zhang C
Pharm Biol; 2016 Sep; 54(9):1857-64. PubMed ID: 26760929
[TBL] [Abstract][Full Text] [Related]
15. Effect of Leptin on Marrow Adiposity in Ovariectomized Rabbits Assessed by Proton Magnetic Resonance Spectroscopy.
Li S; Jiang H; Wang B; Gu M; Zhang N; Liang W; Wang Y
J Comput Assist Tomogr; 2018; 42(4):588-593. PubMed ID: 29489596
[TBL] [Abstract][Full Text] [Related]
16. Sequential treatment with monofluorophosphate and zoledronic acid in osteoporotic rats.
Brance ML; Brun LR; Di Loreto VE; Lupo M; Rigalli A
Climacteric; 2014 Aug; 17(4):478-85. PubMed ID: 24205901
[TBL] [Abstract][Full Text] [Related]
17. Long-term minodronic acid (ONO-5920/YM529) treatment suppresses increased bone turnover, plus prevents reduction in bone mass and bone strength in ovariectomized rats with established osteopenia.
Tanaka M; Mori H; Kayasuga R; Ochi Y; Kawada N; Yamada H; Kishikawa K
Bone; 2008 Nov; 43(5):894-900. PubMed ID: 18687415
[TBL] [Abstract][Full Text] [Related]
18. Effects of Total Flavonoids of Epimedium on Bone Marrow Adipose Tissue in Ovariectomized Rats.
Chen L; Ma R; Luo P; Shi D; Shi X; Nian H; Chang SX; Yuan W; Li GW
Front Endocrinol (Lausanne); 2022; 13():900816. PubMed ID: 35733771
[TBL] [Abstract][Full Text] [Related]
19. Droloxifene, a new estrogen antagonist/agonist, prevents bone loss in ovariectomized rats.
Ke HZ; Simmons HA; Pirie CM; Crawford DT; Thompson DD
Endocrinology; 1995 Jun; 136(6):2435-41. PubMed ID: 7750465
[TBL] [Abstract][Full Text] [Related]
20. Long-term zoledronic acid treatment increases bone structure and mechanical strength of long bones of ovariectomized adult rats.
Hornby SB; Evans GP; Hornby SL; Pataki A; Glatt M; Green JR
Calcif Tissue Int; 2003 Apr; 72(4):519-27. PubMed ID: 12574877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]